A new study in JAMA Network Open suggests that disparities in outcomes between Black and White children with acute myeloid ...

Results from the phase 3 NOTUS trial presented at the ATS meeting confirm benefits of Dupixent (dupilumab) among 20% to 40% ...

Pamrevlumab is the third investigational agent to fail in a phase 3 trials. Researchers said It may be time to stop treating ...

Breast cancer stats from the American Association for Cancer Research 2024 Cancer Disparities Report. Although there has been ...

New study finds that daytime heat waves were associated with 19% higher odds of children’s asthma hospital visits. Longer ...

Medicare patients who have pulmonary arterial hypertension and who are eligible for the low-income subsidy often have ...

Hundreds linked up to have their picture taken with Will Flanary, M.D., an ophthalmlogist in Portland, Oregon, and a hugely ...

The FDA has approved a new type of bispecific antibody to treat small cell lung cancer and an additional indication for ...

William Flanary, M.D.., has a huge social media following as Dr. Glaucomflecken, a character he created on Twitter when he ...

Debra Boyer, M.D., M.H.P.E., discussed the program of the 2024 American Thoracic Society International Conference in San Diego and the limits of artificial intelligence. In some areas of the country, ...

Some research has suggested that omega-3 fatty acid supplements could help treat dry eye disease. But Korean investigators ...

According to findings collected by Cedars-Sinai, artificial intelligence can reduce serious health risks associated with ...